-
1
-
-
79961108629
-
Reduced lung-cancer mortality with low-dose computed tomographic screening
-
National Lung Screening Trial Research Team Aberle, D.R., Adams, A.M., Berg, C.D., Black, W.C., Clapp, J.D., Fagerstrom, R.M., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365 (2011), 395–409, 10.1056/NEJMoa1102873.
-
(2011)
N Engl J Med
, vol.365
, pp. 395-409
-
-
Aberle, D.R.1
Adams, A.M.2
Berg, C.D.3
Black, W.C.4
Clapp, J.D.5
Fagerstrom, R.M.6
-
2
-
-
84938514714
-
Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography
-
Infante, M., Cavuto, S., Lutman, F.R., Passera, E., Chiarenza, M., Chiesa, G., et al., DANTE Study Group. Long-term follow-up results of the DANTE trial, a randomized study of lung cancer screening with spiral computed tomography. Am J Respir Crit Care Med 191 (2015), 1166–1175, 10.1164/rccm.201408-1475OC.
-
(2015)
Am J Respir Crit Care Med
, vol.191
, pp. 1166-1175
-
-
Infante, M.1
Cavuto, S.2
Lutman, F.R.3
Passera, E.4
Chiarenza, M.5
Chiesa, G.6
-
3
-
-
84979093897
-
Results of the randomized Danish lung cancer screening trial with focus on high-risk profiling
-
Wille, M.M., Dirksen, A., Ashraf, H., Saghir, Z., Bach, K.S., Brodersen, J., et al. Results of the randomized Danish lung cancer screening trial with focus on high-risk profiling. Am J Respir Crit Care Med 193 (2016), 542–551, 10.1164/rccm.201505-1040OC.
-
(2016)
Am J Respir Crit Care Med
, vol.193
, pp. 542-551
-
-
Wille, M.M.1
Dirksen, A.2
Ashraf, H.3
Saghir, Z.4
Bach, K.S.5
Brodersen, J.6
-
4
-
-
84859295557
-
Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial
-
Pastorino, U., Rossi, M., Rosato, V., Marchianò, A., Sverzellati, N., Morosi, C., et al. Annual or biennial CT screening versus observation in heavy smokers: 5-year results of the MILD trial. Eur J Cancer Prev 21 (2012), 308–315, 10.1097/CEJ.0b013e328351e1b6.
-
(2012)
Eur J Cancer Prev
, vol.21
, pp. 308-315
-
-
Pastorino, U.1
Rossi, M.2
Rosato, V.3
Marchianò, A.4
Sverzellati, N.5
Morosi, C.6
-
5
-
-
85071173152
-
Prolonged lung cancer screening reduced 10-year mortality in the MILD trial
-
Pastorino, U., Silva, M., Sestini, S., Sabia, F., Boeri, M., Cantarutti, A., et al. Prolonged lung cancer screening reduced 10-year mortality in the MILD trial. Ann Oncol, 2019, 10.1093/annonc/mdz117.
-
(2019)
Ann Oncol
-
-
Pastorino, U.1
Silva, M.2
Sestini, S.3
Sabia, F.4
Boeri, M.5
Cantarutti, A.6
-
6
-
-
84912102539
-
Computed tomographic characteristics of interval and post screen carcinomas in lung cancer screening
-
Scholten, E.T., Horeweg, N., de Koning, H.J., Vliegenthart, R., Oudkerk, M., Mali, W.P., et al. Computed tomographic characteristics of interval and post screen carcinomas in lung cancer screening. Eur Radiol 25 (2015), 81–88, 10.1007/s00330-014-3394-4.
-
(2015)
Eur Radiol
, vol.25
, pp. 81-88
-
-
Scholten, E.T.1
Horeweg, N.2
de Koning, H.J.3
Vliegenthart, R.4
Oudkerk, M.5
Mali, W.P.6
-
7
-
-
85069569082
-
Efficacy of lung cancer screening appears to increase with prolonged intervention: results from the MILD trial and a meta-analysis
-
Rota, M., Pizzato, M., La Vecchia, C., Boffetta, P., Efficacy of lung cancer screening appears to increase with prolonged intervention: results from the MILD trial and a meta-analysis. Ann Oncol, 2019, 10.1093/annonc/mdz145.
-
(2019)
Ann Oncol
-
-
Rota, M.1
Pizzato, M.2
La Vecchia, C.3
Boffetta, P.4
-
8
-
-
84957711236
-
Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen
-
Sverzellati, N., Silva, M., Calareso, G., Galeone, C., Marchianò, A., Sestini, S., et al. Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen. Eur Radiol 26 (2016), 3821–3829.
-
(2016)
Eur Radiol
, vol.26
, pp. 3821-3829
-
-
Sverzellati, N.1
Silva, M.2
Calareso, G.3
Galeone, C.4
Marchianò, A.5
Sestini, S.6
-
9
-
-
85056383368
-
Long-term active surveillance of screening detected subsolid nodules is a safe strategy to reduce overtreatment
-
Silva, M., Prokop, M., Jacobs, C., Capretti, G., Sverzellati, N., Ciompi, F., et al. Long-term active surveillance of screening detected subsolid nodules is a safe strategy to reduce overtreatment. J Thorac Oncol 13 (2018), 1454–1463, 10.1016/j.jtho.2018.06.013.
-
(2018)
J Thorac Oncol
, vol.13
, pp. 1454-1463
-
-
Silva, M.1
Prokop, M.2
Jacobs, C.3
Capretti, G.4
Sverzellati, N.5
Ciompi, F.6
-
10
-
-
85066263851
-
MILD trial, strong confirmation of lung cancer screening efficacy
-
Schabath, M.B., Aberle, D.R., MILD trial, strong confirmation of lung cancer screening efficacy. Nat Rev Clin Oncol, 2019, 10.1038/s41571-019-0231-3.
-
(2019)
Nat Rev Clin Oncol
-
-
Schabath, M.B.1
Aberle, D.R.2
-
11
-
-
84895793884
-
Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force
-
de Koning, H.J., Meza, R., Plevritis, S.K., ten Haaf, K., Munshi, V.N., Jeon, J., et al. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force. Ann Intern Med 160 (2014), 311–320, 10.7326/M13-2316.
-
(2014)
Ann Intern Med
, vol.160
, pp. 311-320
-
-
de Koning, H.J.1
Meza, R.2
Plevritis, S.K.3
ten Haaf, K.4
Munshi, V.N.5
Jeon, J.6
-
12
-
-
84962611185
-
Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial
-
Patz, E.F. Jr., Greco, E., Gatsonis, C., Pinsky, P., Kramer, B.S., Aberle, D.R., Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial. Lancet Oncol 17 (2016), 590–599, 10.1016/S1470-2045(15)00621-X.
-
(2016)
Lancet Oncol
, vol.17
, pp. 590-599
-
-
Patz, E.F.1
Greco, E.2
Gatsonis, C.3
Pinsky, P.4
Kramer, B.S.5
Aberle, D.R.6
-
13
-
-
85050976448
-
Lung cancer risk to personalise annual and biennial follow-up computed tomography screening
-
Schreuder, A., Schaefer-Prokop, C.M., Scholten, E.T., Jacobs, C., Prokop, M., van Ginneken, B., Lung cancer risk to personalise annual and biennial follow-up computed tomography screening. Thorax, 2018, 10.1136/thoraxjnl-2017-211107.
-
(2018)
Thorax
-
-
Schreuder, A.1
Schaefer-Prokop, C.M.2
Scholten, E.T.3
Jacobs, C.4
Prokop, M.5
van Ginneken, B.6
-
14
-
-
85069586260
-
Identification of candidates for longer lung cancer screening intervals following a negative low-dose computed tomography result
-
Robbins, H.A., Berg, C.D., Cheung, L.C., Chaturvedi, A.K., Katki, H.A., Identification of candidates for longer lung cancer screening intervals following a negative low-dose computed tomography result. J Natl Cancer Inst, 2019, 10.1093/jnci/djz041.
-
(2019)
J Natl Cancer Inst
-
-
Robbins, H.A.1
Berg, C.D.2
Cheung, L.C.3
Chaturvedi, A.K.4
Katki, H.A.5
-
15
-
-
84908574660
-
Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening
-
Horeweg, N., van Rosmalen, J., Heuvelmans, M.A., van der Aalst, C.M., Vliegenthart, R., Scholten, E.T., et al. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol 15 (2014), 1332–1341, 10.1016/S1470-2045(14)70389-4.
-
(2014)
Lancet Oncol
, vol.15
, pp. 1332-1341
-
-
Horeweg, N.1
van Rosmalen, J.2
Heuvelmans, M.A.3
van der Aalst, C.M.4
Vliegenthart, R.5
Scholten, E.T.6
-
16
-
-
85035354450
-
Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening
-
Heuvelmans, M.A., Walter, J.E., Vliegenthart, R., van Ooijen, P.M.A., De Bock, G.H., de Koning, H.J., et al. Disagreement of diameter and volume measurements for pulmonary nodule size estimation in CT lung cancer screening. Thorax 73 (2018), 779–781, 10.1136/thoraxjnl-2017-210770.
-
(2018)
Thorax
, vol.73
, pp. 779-781
-
-
Heuvelmans, M.A.1
Walter, J.E.2
Vliegenthart, R.3
van Ooijen, P.M.A.4
De Bock, G.H.5
de Koning, H.J.6
-
17
-
-
85061545524
-
Effects of volume CT lung cancer screening: mortality results of the NELSON randomised-controlled population based trial
-
September 25, 2018; Toronto (CA-ON)
-
de Koning, H., van der Aalst, C., Ten Haaf, K., Oudkerk, M., Effects of volume CT lung cancer screening: mortality results of the NELSON randomised-controlled population based trial. World Congress of Lung Cancer, 2018, 2 September 25, 2018; Toronto (CA-ON).
-
(2018)
World Congress of Lung Cancer
, pp. 2
-
-
de Koning, H.1
van der Aalst, C.2
Ten Haaf, K.3
Oudkerk, M.4
-
18
-
-
84977501755
-
Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval
-
Yousaf-Khan, U., van der Aalst, C., de Jong, P.A., Heuvelmans, M., Scholten, E., Lammers, J.W., et al. Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval. Thorax 72 (2017), 48–56, 10.1136/thoraxjnl-2016-208655.
-
(2017)
Thorax
, vol.72
, pp. 48-56
-
-
Yousaf-Khan, U.1
van der Aalst, C.2
de Jong, P.A.3
Heuvelmans, M.4
Scholten, E.5
Lammers, J.W.6
-
19
-
-
84989170605
-
Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness
-
Goffin, J.R., Flanagan, W.M., Miller, A.B., Fitzgerald, N.R., Memon, S., Wolfson, M.C., et al. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness. Lung Cancer 101 (2016), 98–103, 10.1016/j.lungcan.2016.09.013.
-
(2016)
Lung Cancer
, vol.101
, pp. 98-103
-
-
Goffin, J.R.1
Flanagan, W.M.2
Miller, A.B.3
Fitzgerald, N.R.4
Memon, S.5
Wolfson, M.C.6
-
20
-
-
0035816019
-
Cancer screening in elderly patients: a framework for individualized decision making
-
Walter, L.C., Covinsky, K.E., Cancer screening in elderly patients: a framework for individualized decision making. J Am Med Assoc 285 (2001), 2750–2756.
-
(2001)
J Am Med Assoc
, vol.285
, pp. 2750-2756
-
-
Walter, L.C.1
Covinsky, K.E.2
-
21
-
-
84969884834
-
Patients' knowledge, beliefs, and distress associated with detection and evaluation of incidental pulmonary nodules for cancer: results from a multicenter survey
-
Freiman, M.R., Clark, J.A., Slatore, C.G., Gould, M.K., Woloshin, S., Schwartz, L.M., et al. Patients' knowledge, beliefs, and distress associated with detection and evaluation of incidental pulmonary nodules for cancer: results from a multicenter survey. J Thorac Oncol 11 (2016), 700–708, 10.1016/j.jtho.2016.01.018.
-
(2016)
J Thorac Oncol
, vol.11
, pp. 700-708
-
-
Freiman, M.R.1
Clark, J.A.2
Slatore, C.G.3
Gould, M.K.4
Woloshin, S.5
Schwartz, L.M.6
-
22
-
-
85051631724
-
Cost-utility analysis of a potential lung cancer screening program for a high-risk population in Germany: a modelling approach
-
Hofer, F., Kauczor, H.U., Stargardt, T., Cost-utility analysis of a potential lung cancer screening program for a high-risk population in Germany: a modelling approach. Lung Cancer 124 (2018), 189–198, 10.1016/j.lungcan.2018.07.036.
-
(2018)
Lung Cancer
, vol.124
, pp. 189-198
-
-
Hofer, F.1
Kauczor, H.U.2
Stargardt, T.3
-
23
-
-
85012257334
-
Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis
-
Rampinelli, C., De Marco, P., Origgi, D., Maisonneuve, P., Casiraghi, M., Veronesi, G., et al. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis. BMJ, 356, 2017, j347, 10.1136/bmj.j347.
-
(2017)
BMJ
, vol.356
, pp. j347
-
-
Rampinelli, C.1
De Marco, P.2
Origgi, D.3
Maisonneuve, P.4
Casiraghi, M.5
Veronesi, G.6
-
24
-
-
85029385622
-
Risk stratification based on screening history: the NELSON lung cancer screening study
-
Yousaf-Khan, U., van der Aalst, C., de Jong, P.A., Heuvelmans, M., Scholten, E., Walter, J., et al. Risk stratification based on screening history: the NELSON lung cancer screening study. Thorax 72 (2017), 819–824, 10.1136/thoraxjnl-2016-209892.
-
(2017)
Thorax
, vol.72
, pp. 819-824
-
-
Yousaf-Khan, U.1
van der Aalst, C.2
de Jong, P.A.3
Heuvelmans, M.4
Scholten, E.5
Walter, J.6
-
25
-
-
84989817170
-
Lung cancer screening: latest developments and unanswered questions
-
van der Aalst, C.M., Ten Haaf, K., de Koning, H.J., Lung cancer screening: latest developments and unanswered questions. Lancet Respir Med 4 (2016), 749–761, 10.1016/S2213-2600(16)30200-4.
-
(2016)
Lancet Respir Med
, vol.4
, pp. 749-761
-
-
van der Aalst, C.M.1
Ten Haaf, K.2
de Koning, H.J.3
-
26
-
-
84897015133
-
Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study
-
Sozzi, G., Boeri, M., Rossi, M., Verri, C., Suatoni, P., Bravi, F., et al. Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial study. J Clin Oncol 32 (2014), 768–773, 10.1200/JCO.2013.50.4357.
-
(2014)
J Clin Oncol
, vol.32
, pp. 768-773
-
-
Sozzi, G.1
Boeri, M.2
Rossi, M.3
Verri, C.4
Suatoni, P.5
Bravi, F.6
-
27
-
-
85069585961
-
-
on August 17.
-
Pastorino U, Sestini S. https://clinicaltrials.gov/ct2/show/study/NCT02247453 on August 17 2016.
-
(2016)
-
-
Pastorino, U.1
Sestini, S.2
-
28
-
-
85060116337
-
Biomarkers in lung cancer screening: achievements, promises, and challenges
-
Seijo, L.M., Peled, N., Ajona, D., Boeri, M., Field, J.K., Sozzi, G., et al. Biomarkers in lung cancer screening: achievements, promises, and challenges. J Thorac Oncol 14 (2019), 343–357, 10.1016/j.jtho.2018.11.023.
-
(2019)
J Thorac Oncol
, vol.14
, pp. 343-357
-
-
Seijo, L.M.1
Peled, N.2
Ajona, D.3
Boeri, M.4
Field, J.K.5
Sozzi, G.6
|